Non-Vitamin K Oral Anticoagulant dosing and use – Inappropriate dosing is rife!
AJHP
Saved in:
Main Authors: | Tan D, Wong SL, Chia J, Lim L |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176998 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials
by: Wang KL, et al.
Published: (2020) -
Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: An Asian Perspective
by: Chao T.F.
Published: (2023) -
Underlying Differences in the Treatment of Left Ventricular Thrombus With Non-Vitamin K Antagonist Oral Anticoagulants
by: Leow, Aloysius Sheng-Ting, et al.
Published: (2021) -
Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis
by: Lee, Grace KH, et al.
Published: (2021) -
Efficacy and Safety of Prophylactic-Dose Anticoagulation Therapy with Intermediate-Therapeutic Doses in Covid-19 Patients
by: Diva Rachma Kurniawati, -, et al.